[ad_1]
Invima has just issued a health warning on a drug marketed under the Rhifisol brand, which, the regulator says, is repackaging Interferon, repackaged under this new brand, to be fraudulently marketed as a supposed coronavirus treatment drug.
Interferon is an antiviral drug that works on a cellular level to strengthen the ability of cells to defend themselves, to improve the responsiveness of the immune system, as a treatment for some types of cancer.
It may interest you: There is no evidence that interferon is safe against coronavirus: Invima
Interferon was one of those drugs that together with chloroquine, hydroxychloroquine, remdesivir and lopinavir, among others, they have been the subject of analysis and testing to presumably help treat, to weaken, the coronavirus in infected patients, although recent studies state that they do not have such an effect and that, on the contrary, they can be very counterproductive.
You may be interested in: Beta Interferon: Beware of its eleven dangerous contraindications
Invima orders national and regional authorities, trade and citizens to immediately avoid the marketing and use of Rhifisol and report the suppliers or pharmacies where they sell this illegal drug, manufactured by the Gerco SAS laboratory, which does not have an Invima registration to market Interferon.
This is the Invima health alarm in this regard:
[ad_2]
Source link
